Minimally Classic/Occult Trial of the Anti-VEGF Antibody Ranibizumab in the Treatment of Neovascular Age-Related Macular Degeneration (MARINA)

October 5, 2006

Clinical trial

Ranibizumab for neovascular age-related macular degeneration.

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY.

N Engl J Med. 2006 Oct 5;355(14):1419-31.
Full text

Share This Article :

Updated on March 7th, 2022

Source Archive